24_10_STREAM_SiteHeader_PO

PHARMACEUTICAL ONLINE RECENT WEBINARS

1:00:30 Building A Science- And Risk-Based Bio-Decontamination Strategy
Building A Science- And Risk-Based Bio-Decontamination Strategy

Annex 1 has made bio-decontamination central to sterility assurance, with isolator and barrier cycles now expected to be designed, justified, and reviewed across their lifecycle.

27:56 Accelerating CHO Media Development: From Screening To AI Design
Accelerating CHO Media Development: From Screening To AI Design

Discover how high-throughput screening, process analytics, and AI-guided modeling can help identify promising CHO media and feed combinations faster and support a more predictive approach.

45:20 Lessons In Building Connected Lab Operations Across Development And GMP png
Lessons In Building Connected Lab Operations Across Development And GMP

Building connected operations across development and GMP environments removes bottlenecks and ensures data integrity. Explore practical insights to scale and standardize your lab workflows.

1:02:16 West Design Development Syringes
Design Verification Done Right: Smarter Strategies For Prefillable Syringes

A practical framework for planning and justifying design verification programs for prefillable syringes, covering test selection, acceptance criteria, and sample-size rationale within a risk-based approach.

28:50 Evaluating Modular CAR T Manufacturing Workflows: Performance, Flexibility, And Scale Bucket
Evaluating Modular CAR T Manufacturing Workflows

As CAR T manufacturing scales, balancing throughput, flexibility, and cell quality becomes increasingly complex. Explore strategies for improving process control, reducing bottlenecks, and more.

29:56 Greenfield Global - Sodium Hydroxide webinar
How Sodium Hydroxide CIP Affects Column Performance And Resin Lifetime

Sodium hydroxide CIP is essential for column hygiene, but cleaning decisions carry real tradeoffs for resin longevity and long-term chromatography performance.

39:57 450_300-09_24_26_aes_linkedin_1280x720
Annex 1 In Practice: Turning CCS Into Cleanroom Design

Learn how embedding a contamination control strategy into early facility design mitigates risk, protects product quality, and ensures regulatory compliance.

49:29 Overcoming Concentration Nanoform
Breaking The Concentration Barrier: New Long-Term Stability And PK Data For Subcutaneous Nanotrastuzuma

Nanoparticle engineering enabled a 440 mg/mL trastuzumab suspension that clears viscosity and stability barriers limiting conventional high-dose subcutaneous biologics formulations.

58:46 Accelerating To The Clinic Building Oral Dosage Forms For Speed Today And Success Tomorrow
Building Oral Dosage Forms for Speed Today And Success Tomorrow

Move toward the clinic with confidence using integrated development strategies that support smarter decisions and more efficient product development.

 

28:35 Samsung ADC Immuno
Improving Clinical Translation For ADCs And Immuno-Oncology With Human-Relevant Tumor Models

When preclinical tumor models fail to reflect clinical reality, promising therapies pay the price. This webinar examines how advanced patient-derived organoids and 3D models improve predictive accuracy for ADC and immuno-oncology programs.

28:39 Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production
Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production

Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.

58:02 Driving Productivity Across The Antibody Manufacturing Workflow
Driving Productivity Across The Antibody Manufacturing Workflow

Learn how integrated upstream and downstream strategies can reduce harvest bottlenecks, improve purification efficiency, and support scalable therapeutic antibody manufacturing.

1:00:08 Future-Proofing Your USP <87> Strategy: Preparing For The Next Generation Of Biological Reactivity Testing
The Next Generation Of USP <87> Testing

Upcoming USP <87> changes are driving risk-based in vitro testing. Learn how to prepare for new requirements, validation impacts, and continued compliance.

33:40 De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing
De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing

Explore practical approaches to scaling cell culture media manufacturing, from supply assurance to evolving quality requirements, digital formulation tools, and strategies for controlling costs.

44:47 How To Achieve Stable, High-Output Stickpack Production
How To Achieve Stable, High-Output Stickpack Production

Explore practical ways to improve stickpack production through accurate dosing, reliable sealing, automated quality control, and efficient material handling while reducing complexity.

59:09 Beyond Breakdowns: Building A Culture Of Proactive Maintenance
Beyond Breakdowns: Building A Culture Of Proactive Maintenance

Reactive maintenance can drive costly downtime, deviations, and reliability challenges. Learn how proactive maintenance strategies help improve equipment uptime and strengthen compliance.

59:46 Before IND Know: How to Overcome Early Development Challenges Before They Impact Your Program
Overcome Early Development Challenges Before They Impact Your Program

Poor manufacturability and immunogenicity can delay development. Learn how early developability assessments support IND readiness.

1:00:04 CAI webinar
A CCS Is A Purpose-Built Machine, Not A Black Box: Understand The Workings

Learn how to transform your contamination control strategy into a dynamic operational framework that identifies risks and strengthens facility control.

49:44 Mastercontrol webinar sept 2026
AI-Readiness In A Regulated World: A Practical Playbook For Life Sciences

Uncover how life science teams build defensible governance, maintain human oversight, and manage regulatory risks when adopting advanced digital tools.

40:32 Driving Measurable Productivity Gains In CHO Cell Culture
Driving Measurable Productivity Gains In CHO Cell Culture

Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.

55:54 Container Closure Integrity Testing: Selecting A Test Method For Your Container System
Selecting A Test Method For Your Container System

Selecting CCIT requires matching methods like vacuum decay to product traits. Assess liquid conductivity, headspace, and lifecycle risks to build a compliant leak-detection strategy.

54:11 The Future Of Cell Culture Media Development: Predictive Modeling And AI Bucket
The Future Of Cell Culture Media Development

Predictive modeling and AI are helping reshape cell culture media. Learn how these approaches can focus experimental efforts, accelerate learning, and support more efficient development decisions.

44:28 From Data To Decisions: AI And Multi-Omics For Cell Culture Development Bucket
From Data To Decisions: AI And Multi-Omics For Cell Culture Development

See how combining multi-omics data, AI-enabled analytics, and expertise can reveal the biological drivers of process performance, helping biologics developers identify optimization opportunities.

50:23 Built For Growth Engineering Flexible And Scalable Bioprocessing Strategies img
Built For Growth: Engineering Flexible And Scalable Bioprocessing Strategies

Standardizing bioprocess platforms and automation logic simplifies cross-site tech transfer and mitigates workforce constraints during program scale-up.

47:43 Controlling Nitrosamine Risk In Drug Products: Detection, Formation, And Control Strategies
Controlling Nitrosamine Risk In Drug Products: Detection, Formation, And Control Strategies

Bioprocess control relies on clear insight into cell health. Automated tracking cuts risk, saves time, boosts yield, and helps scale up fast to ensure smooth, top quality batch production runs daily.

28:57 How Modular Workflows Are Redefining CAR T Manufacturing
How Modular Workflows Are Redefining CAR T Manufacturing

Learn how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control while preserving key CAR T quality attributes, including transduction efficiency.

48:25 MCSplash
Navigating AI Compliance In Life Sciences: FDA Policy Insights For AI Governance

Navigating life sciences AI compliance requires strong governance, expert human oversight, and transparent, low-risk deployment strategies.

30:35 Reducing Particulate-Related Batch Risk In Bioprocessing
Reducing Particulate-Related Batch Risk In Bioprocessing

Increasing scrutiny around particulate contamination is pushing teams to act earlier. Understanding where risks originate and applying proactive strategies can ease challenges across production.